PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 90671404 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 128 |
MARK SECTION | |
MARK | BREDAYGIO (see, http://uspto.report/TM/90671404/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | BREDAYGIO |
OWNER SECTION (current) | |
NAME | Adagio Therapeutics, Inc. |
MAILING ADDRESS | 1601 Trapelo Road, Suite 178 |
CITY | Waltham |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02451 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Adagio Therapeutics, Inc. |
MAILING ADDRESS | 1601 Trapelo Road, Suite 178 |
CITY | Waltham |
STATE | Massachusetts |
ZIP/POSTAL CODE | 02451 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | John Paul Oleksiuk |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@cooley.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | landrepont@cooley.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | John Paul Oleksiuk |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@cooley.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | landrepont@cooley.com |
DOCKET/REFERENCE NUMBER | 342961-20000 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical preparations and substances for the treatment and prevention of viruses; chemical, biochemical and microbial products, namely, antibodies being pharmaceutical preparations for the treatment and prevention of viruses |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 03/22/2022 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /Jill Andersen/ |
SIGNATORY'S NAME | Jill Andersen |
SIGNATORY'S POSITION | Chief Legal Officer |
DATE SIGNED | 09/16/2022 |
SIGNATORY'S PHONE NUMBER | N/A |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Fri Sep 16 10:34:49 ET 2022 |
TEAS STAMP | USPTO/ESU-XX.XX.XX.X-2022 0916103449742240-90671404 -800eb4a8c68394850aafb958 1e7dea53f8a05a5dd1553a42d 4faadd5196cab241-DA-34490 008-20220831160441609075 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |